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On the Gene Delivery Efficacies of pH-Sensitive
Cationic Lipids via Endosomal Protonation:
A Chemical Biology Investigation
popularly known as “Transfection Vectors,” are broadly
divided into two major classes: viral and nonviral. The
gene delivery efficiencies of viral vectors are, in general,
superior to their non-viral counterparts. However, poten-
tial adverse immunogenic aftermath associated with the
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Hyderabad 500 007 use of viral vectors is increasingly making nonviral gene
delivery reagents the vectors of choice in gene therapyIndia
2 Centre de Biophysique Mole´culaire [2]. Use of cationic lipids as a promising alternative to
viral transfection vectors has been amply demonstratedCentre National de la Recherche Scientifique
UPR 4301 in reports by researchers around the globe [3–6], our
own reports included [7–9]. The distinct advantages as-Rue Charles Sadron
45071 Orle´ans, Cedex 02 sociated with the use of cationic transfection lipids in-
clude their (i) robust manufacture, (ii) ease in handlingFrance
and preparation techniques, (iii) ability to deliver large
DNA molecules, and (iv) low immunogenic response.
The lipid-mediated intracellular transfection pathwaysSummary
presently believed to be cationic [10, 11] begin by endo-
cytotic cellular uptake of the lipid:DNA complex (li-In an effort to probe the importance of endosomal
protonation in pH-sensitive, cationic, lipid-mediated, poplex). The second step is the release of DNA from an
endosome into the cytosol. An important point needsnon-viral gene delivery, we have designed and synthe-
sized a novel cholesterol-based, endosomal pH-sensi- to be emphasized here. The term “endosomal release
of DNA into cytosol” (used frequently throughout thetive, histidylated, cationic amphiphile (lipid 1), its less
pH-sensitive counterpart with an electron-deficient, text) does not mean a single mechanistic event of the
cellular transfection pathway but rather is used in atosylated histidine head group (lipid 2) as well as a
third new cholesterol-based, cationic lipid containing somewhat broader sense. The mechanistic detail of DNA
release from endosomes into cytosol remains elusive.no histidine head group (lipid 3). For all the novel lipo-
somes and lipoplexes, we evaluated hysicochemical One possibility is that disruption of endosomes liberates
lipoplexes into cytosol and that DNA dissociation fromcharacteristics, including lipid:DNA interactions, global
surface charge, and sizes. As anticipated, lipid 2 the liberated lipoplexes follows as a separate mechanis-
tic event. Alternatively, DNA dissociation from lipoplexesshowed lower efficacies than lipid 1 for the transfec-
tion of 293T7 cells with the cytoplasmic gene expres- may occur before endosome disruption, during endo-
some disruption, or not at all. The endosomally releasedsion vector pT7Luc at lipid:DNA mole ratios of 3.6:1
and 1.8:1; both lipids were greatly inhibited in the pres- DNA then gets translocated into the cell nucleus so that
it can access the nuclear transcription apparatus andence of Bafilomycin A1. This demonstrates the involve-
ment of imidazole ring protonation in the endosomal is finally expressed in the cytosol. A key cellular barrier
impeding the transfection efficacies of cationic lipids isescape of DNA. Conversely, endosome escape of DNA
with lipid 3 seemed to be independent of endosome the inefficient release of endosomally trapped DNA into
the cell cytosol [10, 11]. Assault from the various hy-acidification. However, with nuclear gene expression
systems in 293T7, HepG2, and HeLa cells, the transfec- drolytic enzymes is, understandably, the fate of a thera-
peutic foreign gene if it remains endosomally trappedtion efficacies of lipid 2 at a lipid:DNA mole ratio of
3.6:1 were found to be either equal to or somewhat for a long time before being released to the cytosol. In
order to protect DNA from such hydrolytic digestion bylower than those of lipids 1 and 3. Interestingly, at
a lipid:DNA mole ratio of 1.8:1, lipids 2 and 3 were enhanced endosomal release, Wolff and his coworkers
pioneered the design and synthesis of pH-sensitive, cat-remarkably more transfection efficient than lipid 1 in
ionic transfection lipids containing weakly basic lysoso-both HepG2 and HeLa cells. Mechanistic implications
motropic imidazole head groups [12]. The rationale be-of such contrasting relative transfection profiles are
hind their approach was that the weakly basic imidazoledelineated.
head group, with its pKa being within the acidity range of
endosome lumens (pH 5.5–6.5), acts as a proton spongeIntroduction
while inside the endosome compartments. This so-
called “endosomal buffering” is believed not only toThe problems of developing a clinically viable, gene-
inhibit the degradative enzymes (which perform opti-therapeutic approach and designing safe and efficient
mally within the acidic pH range of the endosome-lyso-gene delivery reagents are inseparable from each other;
some compartments) but also to induce stronger elec-shortcomings in one adversely affect the success of the
trostatic repulsions among the protonated imidazoleother [1]. Contemporary gene delivery reagents, more
head groups of the cationic liposomes, leading to os-
motic swelling and eventual endosomal bursting due to*Correspondence: arabinda@iict.ap.nic.in (A.C.); midoux@cnrs-
water entry [12, 13]. This elegant approach has subse-orleans.fr (P.M.)
3 These authors contributed equally to this work. quently been exploited in designing the next generation
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Figure 1. Synthesis of Lipids 1–3
of cationic transfection lipids [14] and cationic polymers HepG2 cells by using a nuclear-expression gene vector
and in 293T7 cells by using a cytoplasmic gene expres-[15–17], the most such design being our own of histidy-
lated cationic lipid [18]. sion vector. Compared to lipid 1, lipid 2 showed poor
efficacies in transfecting 293T7 cells with a cytoplasmicWe envisioned that if endosomal protonation of
weakly basic head groups indeed plays a major role in gene expression vector (pT7Luc) at lipid:DNA mole ra-
tios of 3.6:1 and 1.8:1, as expected. Their transfectionthe transfection efficacies of pH-sensitive cationic lip-
ids, covalent grafting of an electron-withdrawing sub- efficiencies were reduced significantly in the presence of
Bafilomycin A1, which prevents endosome acidification.stituent in the basic head group should lead to compro-
mised transfection efficacy. With such a rationale in This is consistent with the involvement of imidazole ring
protonation in the endosomal escape of DNA. However,mind, in the present investigation we have designed and
synthesized a novel cholesterol-based, endosomal pH- with nuclear gene expression systems, the transfection
efficacies of lipid 2 at a lipid:DNA mole ratio of 3.6:1sensitive, histidylated, cationic amphiphile, 1, its less
pH-sensitive counterpart, 2, having an electron-defi- was found to be either equal to or somewhat less than
those of lipids 1 and 3. Interestingly, at a lipid:DNA molecient, tosylated histidine head group as well as a third
new cholesterol-based, cationic lipid, 3, containing no ratio of 1.8:1, lipids 2 and 3 were remarkably more trans-
fection efficient than lipid 1 in both HepG2 and HeLahistidine head group (Figure 1). We have evaluated their
in vitro gene delivery efficiencies in 293T7, HeLa, and cells.
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Results and Discussion azole ring protons observed for intermediate II. Similar
chemical shifts for H-2 and H-5 protons of the imidazole
rings of lipids 1 and 2 are likely to originate from theChemistry
Lipids 1–3 were synthesized from the same common fact that the acid deprotection step using relatively con-
centrated trifluoroacetic acid (2:1 trifluoroacetic acidsynthetic intermediate, 2-aminoethyl-cholesteryl-ether
(ACE), prepared conventionally in three steps by conver- [TFA]:water) provides mainly the dicationic form of lipid
1, whereas the acid deprotection step with diluted tri-sion of the corresponding alcohol, 2-hydroxyethyl cho-
lesteryl ether, to its bromo and azido intermediates; this fluoroacetic acid (1:4 TFA:dichloromethane) affords pre-
dominantly the mono-cationic form of lipid 2 (Figure 1).was followed by reduction (details of synthetic schemes
and experimental procedures are provided in the sup- Di-cyclohexyl-carbodiimide-mediated coupling of ACE
with N-BOC-alanine, acid deprotection of the resultingporting information). Carbonyl-di-imidazole-mediated
coupling of N,Nim-di-trityl-L-histidine with ACE, acid de- product, and finally, chloride ion exchange provided
lipid 3, the structural analog of lipid 1 with the histidineprotection of the resulting N,Nim-di-trityl-L-histidinyl in-
termediate, and finally, chloride ion exchange of the functionality substituted by a hydrogen atom (Figure 1C).
detritylated product afforded lipid 1, containing an un-
substituted histidine head group containing a proton-
Relative Endosomal pH Sensitivities andated imidazole ring (Figure 1A). Upon di-cyclohexyl-car-
Physicochemical Characterizations of thebodiimide coupling with N,Nim-di-BOC-L-histidine, ACE
Liposomes and Lipoplexes of Lipids 1–3afforded the di-BOC intermediate (product of step a,
Relative pH sensitivities of lipids 1–3 in the endosomalFigure 1B; BOC stands for di-tert-butyl-pyrocarbonate).
acidity range (pH 6.5–5.5) were measured from the ex-As expected, both the Nim-BOC peak (at  1.6 ppm) and
tent of surface-potential changes of the correspondingthe N-BOC peak (at  1.4 ppm) in the 1H NMR spectra
liposomes (1,2-dioleoyl-sn-glycero-3-phosphoethanola-of the reagent N,Nim-di-BOC-L-histidine (commercially
mine [DOPE] was used as the colipid, and the lipid:DOPEavailable) were present in the 1H NMR spectra of the
mole ratio was 2:1) and lipoplexes across the pH rangeresulting di-BOC intermediate formed in step a of Figure
7.0–5.4 at lipid:DNA (L:D) mole ratios 3.6:1 and 1.8:1 (zeta1B (1H NMR spectra of this di-BOC intermediate are
potentials, Table 1). The surface potentials of liposome 1provided in Figure S3 of the Supplemental Data available
were observed to be significantly higher than those ofwith this article online).
liposome 2, particularly within the endosomal pH-rangeThe di-BOC intermediate formed in step a of Figure
(Table 1,  values in absence of DNA for lipids 1 and 2 at1B, upon selective histidine-BOC deprotection with 2N
pH 6.3 and 5.4). Such significantly higher global surfaceHCl/dioxan, afforded the mono-BOC intermediate con-
potentials for liposome 1 than for liposome 2 at pH 6.3taining an unsubstituted histidine (the product formed in
and 5.4 demonstrated the more endosomal-pH-sensi-step b, Figure 1B). In complete agreement with selective
tive nature of lipid 1 compared to lipid 2. The higherremoval of the Nim-BOC group, the product formed in
pH sensitivity of lipid 1 compared to lipid 2 most likelystep b, Figure 1B, showed disappearance of the Nim-
originates from the relatively less basic nature of lipidBOC peak (at  1.6 ppm) and retention of the N-BOC
2 than lipid 1 (as a result of the electron-withdrawingpeak (at  1.4 ppm) of the starting di-BOC intermediate
tosyl functionality in the histidine ring of lipid 2). In other(1H NMR spectra of this N-BOC intermediate, formed
words, the extent of endosomal protonation for lipid 1in step b, Figure 1B, are provided in Figure S4 of the
is likely to be significantly higher than that for lipid 2,Supplemental Data). Tosylation of this mono-BOC inter-
thereby conferring enhanced positive surface charge onmediate provided the N-BOC-Nim-tosyl intermediate II
the liposome 1 at the lower pH end (Table 1). Interest-(Figure 1B). The 1H NMR spectra of the intermediate II
ingly, the surface potentials of liposome 3 with no histi-showed the expected downfield shift for both of the
dine functionality in the head group were found to beimidazole ring protons adjacent to the Nim-tosyl group
highly positive in the entire endosomal-pH range in the(Figure 1B) as compared to their values in the starting
absence of DNA (Table 1). The surface potential of lipo-unsubstituted histidine intermediate (the observed val-
some 3 in the absence of DNA increased by about 20ues were 7.80 (H2-im) and 7.00 (H5-im) for the tosyl inter-
mV as the pH decreased from 7.0 to 6.3 (from 37 mV atmediate II and 7.70 (H2-im) and 6.82 (H5-im) for the start-
pH 7.0 to 57 mV at pH 6.3, Table 1). The correspondinging unsubstituted histidine intermediate, respectively;
increase for liposome 1 was about 40 mV (from 8 mV1H NMR spectra are provided in Figures S4 and S5 of
at pH 7.0 to 31 mV at pH 6.3, Table 1). This relativelythe Supplemental Data). These 1H NMR shifts are fully
lower increase in surface potential for liposome 3 wasconsistent with the similar relative downfield shifts re-
consistent with the relatively less endosomal-pH-sensi-ported previously for both of the adjacent protons of
tive character of lipid 3 compared to lipid 1.the tosylated histidine molecule in the 1H NMR spectra in
According to the current beliefs about an endosomalcomparison to their unsubstituted histidine counterpart
DNA escape mechanism mediated by pH-sensitive cat-[19]. Acid deprotection of II and subsequent chloride ion
ionic transfection lipids, endosomal release of DNA intoexchange finally afforded lipid 2, the structural analog of
the cytosol should critically depend upon efficient pro-lipid 1 containing an electron-deficient imidazole head
tonation of the weakly basic head groups of pH-sensitivegroup (Figure 1B). The 1H NMR spectra of lipid 2 (pro-
lipids in the acidic lumen of endosomes. In other words,vided in Figure S6 of the Supplemental Data) confirmed
efficient cytosolic release of DNA and, therefore, en-the disappearance of the nine N-BOC protons and re-
tention of both of the downfield-shifted, tosylated imid- hanced transfection efficiency is expected from the rela-
Chemistry & Biology
716
Table 1. Zeta Potentials () of Liposomes and Lipoplexes at Lipid:DNA Mole Ratios 3.6 and 1.8
Zeta Potential (mV)a
Lipid 1 Lipid 2 Lipid 3
Lipid/DNA molar ratio Lipid/DNA molar ratio Lipid/DNA molar ratio
DNA 3.6 1.8  DNA 3.6 1.8  DNA 3.6 1.8
pH 7.0 8 2 44.5  6 44.9  2 15  8 28  3 31  9 37  1.5 26  5 32.5  3
pH 6.3 31  3 28  4 40  2 4.3  7 20.5  2 21  1 57  5 45  4 21  2
pH 5.4 36  9 18  12 35  2 17  2.5 13  2 17  2.5 53  9 59  3 35  8
a The  potentials were measured by the laser light-scattering technique with ZetaSizer 3000 (Malvern Instruments, Orsay, France). The system
was calibrated with DTS 5050 standard from Malvern.
tively more endosomal-pH-sensitive lipid 1 (compared When mixed with DNA, liposomes of lipids 1–3 formed
to lipids 2 and 3). A careful look at the global surface the corresponding lipoplexes. With a view to further
charges ( potential values) of lipoplexes 1–3 across the characterize the resulting lipoplexes, we measured the
pH range 7.0–5.4 at an L:D ratio 3.6:1 revealed that strength of their lipid:DNA binding interactions by using
they were remarkably negative for lipoplexes 1 and 2, the conventional gel retardation assay and determined
whereas those for lipoplex 3 were positive at neutral the lipoplex sizes by using quasi-elastic laser light scat-
pH (Table 1). Lipoplex 1 became positive (about 60 mV tering (QELS) techniques. As shown by agarose gel elec-
enhancement) when the pH dropped from 7.0 to 5.4 as trophoresis, the majority of DNA associated with li-
a result of the imidazole protonation of lipid 1, whereas poplex 1 did not migrate at an L:D of 3.6:1 but rather
lipoplex 2 remained negative, as expected because of migrated at ratios of 1.8:1 and 0.9:1 (Figure 2). DNA
the electron-withdrawing tosyl functionality in the histi- migration was not completely retarded with lipid 2 at an
dine ring of this lipid. The global surface charges of L:D of 3.6:1, but complete retardation was reached at an
lipoplex 3 increased less (33 mV) between pH 7.4 and L:D of 7.2:1 (not shown), indicating that DNA interactions
5.4. Thus, our results for lipoplex global surface potential with liposome 1 were stronger than with liposome 2. In
at an L:D ratio 3.6:1 are consistent with lipid 1 being contrast, liposome 3 interacted with DNA more strongly
more pH-sensitive than lipids 2 and 3. than with liposomes 1 and 2. DNA was completely re-
Apparent pKa values of the imidazole groups of lipids 1 tarded even at an L:D of 1.8:1 with lipid 3.
and 2 (dissolved in 0.5% aqueous Triton X-100 solution) QELS measurements showed that lipoplexes 1 and 3
were measured to be 5.5 and 5.0, respectively, from the (at L:D 3.6:1) exhibited a size of 205  60 nm and 188 
differential pH titration curves as described by Wolff and 55 nm, respectively, whereas lipoplex 2 exhibited a pop-
his coworkers [12]. Thus, if one assumes 5.5–6.5 to be ulation of 428  166 nm mixed with aggregates of 2058
the endosomal pH range, the imidazole ring of lipid 2 nm. The size of lipoplexes 1 and 3 increased up to
with tosylated histidine functionality is likely to be less 328  118 nm and 323  90 nm, respectively, under
protonated than lipid 1 inside the acidic endosomal lu- physiological salt concentration, whereas lipoplex 2 ag-
men. However, it needs to be emphasized here that the gregated.
pKa values of the water-insoluble lipids 1 and 2 were
estimated in the presence of aqueous nonionic Triton
Transfection with Cytoplasmic GeneX-100 micelles (used for keeping lipids 1 and 2 in solu-
Expression Vectortion). Typically, shifts of 1 or 2 in the apparent pKa values
The cytosolic delivery of DNA can be assessed by theof many water-soluble weak acids upon their binding
use of T7 cytoplasmic gene expression vector (pT7Luc)with micellar pseudophase is common; the contributing
in 293T7 cells. These cells stably express a low levelfactors responsible for such observed pKa shifts are
of T7 RNA polymerase, an enzyme necessary for themany and include polarity of the micelle surface, micelle
cytoplasmic transcription of genes controlled by thesurface potential, exact localization of the acids within
bacteriophage T7 RNA polymerase promoter. The usethe micellar pseudophase, etc [20]. Extreme examples
of this system that is capable of ensuring cytoplasmicof pKa shifts of 4 units have also been reported for some
expression of transferred genes is an elegant way tocarbon acids bound to a micellar surface [21]. Thus, the
avoid nuclear barrier of the transfection pathway [22].pKa values of water-insoluble acids measured in micel-
In an effort to probe the relative cytosolic DNA deliverylar solutions should be taken as crude estimates of
efficiencies, we measured transfection efficacies of lip-acidities. Given the water-insoluble and amphiphilic
ids 1–3 in 293T7 cells by using pT7Luc. Transfectionstructures of lipids 1 and 2, both of them are likely to
efficacy of the less pH-sensitive lipid 2 was completelycompletely associate themselves within the micellar
abolished at an L:D ratio of 1.8:1 and was about 10-foldpseudophases of Triton X-100 micelles. Thus, it may
lower than that of lipid 1 at an L:D ratio of 3.6:1 (Figurenot be unlikely that the apparent pKa value of lipid 2
3A). If one assumes that the accessibility of the T7 RNAmeasured in the presence of 0.5% Triton X-100 solution
polymerase was the same in lipoplexes 1 and 2 at ancan differ by 1–2 pKa units from the pKa values of its
L:D ratio of 3.6:1, this result indicates that the endosomalrelatively more water-soluble, low-molecular analogs,
release of DNA was better with lipid 1 than with lipid 2such as, 1-tosyl-imidazole (pKa 2.61 at 25C) or, more
appropriately, Nim-tosyl-Histidine methyl ester, etc. containing an electron-deficient histidine head group.
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Figure 2. Electrophoretic DNA Migration Re-
lated to the Lipid:DNA Mole Ratio
Lanes 2–4 correspond to the migration of li-
poplexes at a lipid:DNA mole ratio (L:D) of
3.6:1, 1.8:1, and 0.9:1, respectively. Lane 1
corresponds to the migration of DNA alone.
Electrophoresis was conducted for 1 hr under
80 V/cm through a 0.6% agarose gel con-
taining ethidium bromide (1 g/ml) in 95 mM
Tris, 89 mM boric acid, and 2.5 mM EDTA
(pH 8.6).
Figure 3A also shows that the luciferase activity was 5- The involvement of acid-mediated endosomal escape
of DNA was assessed with Bafilomycin A1 and chlo-to 500-fold higher with lipid 3 than with lipid 1, depending
roquine. Bafilomycin A1 prevents endosomal acidifica-on the L:D ratio. If one assumes that the accessibility
tion by inhibiting the vacuolar ATPase endosomal protonof the T7 RNA polymerase was the same in lipoplexes
pump [23]. The luciferase activity with lipids 1 and 2 was1 and 3, this result indicates that the endosomal release
inhibited by 85% and 76%, respectively, in the presenceof DNA was better with lipid 3 than with lipid 1.
of 280 nM Bafilomycin A1, whereas with lipid 3 it was
reduced by 45% (Figure 3B). At a lower concentration
(55 nM), bafilomycin inhibition of lipids 1 and 2 was 69%
and 67%, respectively, whereas that of lipid 3 was 8%
(data not shown). This means that the endosomal es-
cape of DNA with lipids 1 and 2 requires endosome
acidification and involves the histidine head group of
the lipids. Endosomal pH rises upon protonation of the
weakly basic imidazole head groups of lipids 1 and 2.
Such increased luminal pH could induce membrane re-
organization and thereby facilitate DNA release into the
cytosol. In contrast, the cytosolic release of DNA with
lipid 3 is less dependent on endosome acidification.
In the presence of 100 M chloroquine, the luciferase
activity with lipid 2 was reduced by 45%, whereas that
with lipids 1 and 3 was not significantly changed (Figure
3B). The meaning of the effect of chloroquine on the
transfection efficiency of lipids 1–3 is more difficult to
explain than that of Bafilomycin A1. Indeed, chloroquine
is a weak base known to interfere with endocytosis pro-
cesses, particularly by raising the luminal pH of acidic
vesicles and by delaying the delivery to lysosomes and
lysosomal degradations. In addition, chloroquine in-
creased transfection efficiency of polyplexes and was
found to dissociate polyplexes [24]. As evidenced by
Bafilomycin A1 experiments, lipids 1 and 2 need endo-
some acidification. The decrease of lipid 2 efficiency
could come from either chloroquine neutralization of
vesicles containing lipoplex 2 or inhibition of the delivery
of lipoplex 2 in acidic vesicles. Choroquine had no effect
on lipid 1 because DNA escape might occur at a weak
acidic pH in early vesicles where chloroquine accumula-
Figure 3. Transfection of 293T7 Cells with Lipids 1–3 by the Cyto- tion is weak. This is in agreement with the pKa values
plasmic Gene Expression Vector pT7Luc of the imidazole groups of lipids 1 and 2. As with Bafilo-
(A) The lipid:DNA mole ratios were 3.6:1 (black bar) and 1.8:1 (open mycin A1, chloroquine had no effect on lipid 3 efficiency,
bar). (B) Transfection was carried out with a lipid:DNA mole ratio of confirming that DNA delivery in the cytosol did not de-
3.6:1 in the presence of either Bafilomycin A1 (280 nM, open bar) pend on endosome acidification. This is also the case
or chloroquine (100 M, black bar), where (percent of control) values
for liposomes made with DOTAP. Conversely, the trans-refer to the relative luciferase activities compared to values in ab-
fection efficiency was reduced in the presence of bothsence of Bafilomycin A1 or chloroquine. The luciferase activity was
Bafilomycin A1 and chloroquine with liposomes mademeasured upon 24 hr of culture. The transfection values shown are
average of three independent experiments. with DC-Chol:DOPE [22].
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Figure 4. Transfection of 293T7 Cells with Lipids 1–3 by the Cytoplasmic Gene Expression Vector pCMVLuc
Transfection of 293T7 (A), HeLa (B), and HepG2 cells (C) by the nuclear gene expression vector (pCMVLuc) with lipids 1–3 at lipid:DNA mole
ratios of 3.6 (black bar) and 1.8 (open bar). (D) Transfection of 293T7 cells by lipids 1–3 via the nuclear gene expression vector pCMVLuc in
the presence of Bafilomycin A1 (280 nM, open bar) or chloroquine (100 M, black bar), where (percent of control) values refer to the relative
luciferase activities compared to values in the absence of Bafilomycin A1 or chloroquine. The luciferase activity was measured upon 48 hr of
culture. The transfection values shown are averages of three independent experiments.
Transfection Biology in Nuclear-Expression of 3.6:1 in 293T7 cells in the presence of Bafilomycin
A1 or chloroquine when nuclear expression vectors wereSystems
The transfection profiles of lipids 1–3 at an L:D of 3.6:1 in used (Figure 4D) were not significantly different from
those obtained when cytosolic expression systems were293T7, HeLa, and HepG2 cells when nuclear expression
vectors were used were found to be not significantly used (Figure 3B). The luciferase activity with lipids 1–3
was inhibited by 93%, 50%, and 57%, respectively, indifferent than those in the cytosolic expression systems
described above for 293T7 cells (Figure 4). Although the the presence of 280 nM Bafilomycin A1 (Figure 4D).
In the presence of 100 M chloroquine, the luciferasehistidine ring of lipid 2 was less basic than that of lipid
1 and therefore was less likely to undergo endosomal activity with lipid 2 was reduced by 22%, whereas that
with lipids 1 and 3 was not significantly changed. Thisprotonation, the transfection efficiency of lipid 2 was
observed to be comparable to that of lipids 1 and 3 in suggests that the extent of DNA’s escape from the endo-
cytotic vesicles is directly related to the transfectionHeLa cells and only somewhat less competent in 293T7
and HepG2 cells. The transfection with lipoplex 3 with- efficiency.
Clearly, the relative transfection efficiencies of lipo-out a histidine head group was comparable to that of
the other lipoplexes in all three cell lines. At an L:D ratio some 2 cannot be explained only on the basis of the
pH sensitivity of lipid 2 or lipoplex 2 and of their capacityof 1.8:1, the less-pH-sensitive lipid 3 was observed to
be almost 250-fold more transfection efficient than the for endosomal escape. Because there are multiple steps
leading to cell transfection, the cytosolic delivery of DNApH-sensitive cationic lipid 1 in both HeLa and HepG2
cells. Surprisingly, despite being less pH sensitive than and the nuclear import of DNA are probably not the only
major limiting factors. Indeed, the uptake mechanismslipid 1, lipid 2 showed remarkably high transfection effi-
ciencies in the three cell lines at L:D 1.8:1. The MTT- of lipoplexes could also be a critical step. Flow cytome-
try measurement indicated that the amount of DNAbased cell viability assay in both HeLa and HepG2 cells
(Figure 5) demonstrated that lipids 1–3 were completely taken up by 293T7 cells was similar regardless of what-
ever lipoplexes were used (Table 2). Therefore, the rela-nontoxic in the entire concentration range used, thereby
ruling out any possible role of cytotoxicity in transfection tive variation of the transfection efficiency for each li-
poplex did not come from their uptake efficacy. Indeed,efficiency modulation for the present lipids.
The transfection profiles of lipids 1–3 at an L:D ratio pH-sensitive cationic lipid mediated endosomal release
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on the amount of lipoplexes routed via such acidic vesi-
cles and on their acidification extent, an endosomal es-
cape through an acid-dependent membrane destabili-
zation induced by the histidylated lipid 1 can occur.
Conversely, lipoplex 2 exhibiting large size (aggregates)
could be taken up mainly via clathrin-independent endo-
cytosis, i.e., macropinocytosis or phagocytosis in neu-
tral or weakly acidic vesicles. In this case, cytosolic gene
delivery mediated through acidic-vesicle-dependent
membrane destabilization is likely to be less sensitive.
Moreover, upon internalization, lipoplexes are usually
dissociated by the anionic lipids of the endosomal mem-
brane [11, 28]. One can imagine that liposomes and DNA
segregate in different vesicles with a rate depending on
the strength of DNA-lipid interactions in the lipoplexes.
As shown by gel electrophoresis, the interactions of
DNA with liposome 3 was higher than with liposome 1,
and the lipid:DNA interactions in lipoplex 1 were stronger
than those in lipoplex 2 (Figure 2). As a consequence,
a rapid segregation can lead mainly to DNA-containing
vesicles with no anionic lipids to help them pass into
the cytosol, and the transfection efficacy gets seriously
compromised.
Significance
In an effort to probe the importance of endosomal
protonation in pH-sensitive, cationic, lipid-mediated,
nonviral gene delivery, we have designed and synthe-
Figure 5. Cell Viability after Transfection sized a novel cholesterol-based, endosomal pH-sensi-
Colorimetric MTT assay-based percent cell viabilities of lipids 1–3 tive, histidylated, cationic amphiphile (lipid 1), its less
at lipid:DNA mole ratios 3.6 (black bar) and 1.8 (open bar) in HeLa pH-sensitive counterpart having an electron-deficient,
(A) and HepG2 (B) cells. tosylated histidine head group (lipid 2), as well as a
third new cholesterol-based, cationic lipid containing
no histidine head group (lipid 3). For all of the novel
of DNA requires that lipoplexes routes via acidic vesi- liposomes and lipoplexes, we evaluated physicochem-
cles. The relative transfection profiles of lipoplexes 1–3 ical characteristics, including lipid:DNA interactions,
can reflect differences in their uptake mechanisms global surface charge, and sizes. Using the cyto-
which, in turn, depends on the size of lipoplexes. Indeed, plasmic gene expression system, we have shown that
large lipoplexes (up to 500 nm) might enter cells by the cytosolic delivery of DNA with the pH-sensitive,
clathrin-independent endocytosis, whereas small li- histidylated lipid 1 was higher than with lipid 2 bearing
poplexes (200 nm) could be taken up through a nonspe- less pH-sensitive histidine head group. This result is
cific clathrin-dependent process [25, 26]. It was also consistent with involvement of the imidazole proton-
reported that microspheres with a diameter less than ation of lipid 1 in the DNA endosomal escape from
200 nm are taken up via clathrin-coated pits but that acidic vesicles. The transfection efficiency with the
the entry of particles of 500 nm is mediated by caveolae- new cholesterol-based, cationic lipid 3 bearing no his-
mediated internalization [27]. Lipoplexes 1 and 3, with tidine head group was not very sensitive to endosome
heterogeneous populations of an average size centered acidification. However, with nuclear gene expression
around 300 nm and containing large and small li- systems in 293T7, HepG2, and HeLa cells, the transfec-
poplexes, might mainly enter cells via clathrin-depen- tion efficacies of the less pH-sensitive lipid 2 at
dent endocytosis through acidic vesicles. Depending lipid:DNA mole ratios of 3.6:1 were found to be either
equal to or slightly less than those of lipids 1 and 3.
Surprisingly, at a lipid:DNA mole ratio of 1.8:1, less
Table 2. Uptake of DNA by 293T7 Cells pH-sensitive lipids 2 and 3 were remarkably more
Cell-associated Fluorescence transfection efficient than lipid 1 in both HepG2 and
(Arbitrary Units) HeLa cells. Transfection efficacies of lipids 1–3 in both
cytosol and nuclear expression systems and all their2 hr 4 hr
physicochemical characteristics, taken together, clearly
Lipoplex 1 18 32
indicate that the relative transfection efficiencies ofLipoplex 2 23 27
pH-sensitive cationic lipids cannot be explained onlyLipoplex 3 28 41
on the basis of the pH sensitivity of each lipid or li-
Lipoplexes were formed at a lipid:DNA mole ratio of 3.6:1. poplex.
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Experimental Procedures methane was added to the reaction mixture; stirring continued at
room temperature for 28 hr. The precipitate obtained was filtered,
and the filtrate was concentrated on a rotary evaporator. Column-General Procedures and Materials
1H NMR spectra were recorded on a Varian FT 200 MHz, AV 300 chromatographic purification (with 60–120 mesh size silica and
50%–60%, v/v, ethyl acetate in hexane as the eluent) of the residueMHz or Varian Unity 400 MHz. Carbon tetrabromide, L-histidine,
and Amberlyst A-26 were purchased from Lancaster (Morecambe, afforded the product Nim, N-di-BOC-histidine-cholesteryl-ethylam-
ide as a white solid (1.04 gm, 35% yield, Rf 	 0.5 in 70% ethylEngland). Carbonyl diimidazole was procured from Fluka, Switzer-
land. N,N-di-trityl-L-histidine was synthesized according to pre- acetate in hexane).
1H NMR of Nim, N di-BOC-histidine-cholesteryl-ethylamide (200viously published procedures [29]. Unless otherwise stated, all other
reagents purchased from local suppliers were of analytical grades MHz, CDCl3):  	 0.65–2.30 [m, 43H, cholesteryl skeleton], 1.40 [s,
9H, (CH3)3COCONH-], 1.60 [s, 9H, (CH3)3COCONim-], 2.80–3.15 [m,and were used without further purification. Column chromatography
was performed with silica gel (Acme Synthetic Chemicals, India, 3H, H
(His)H3(Chol)], 3.30–3.50 [m, 4H, -CONH-CH2-CH2-O-], 4.38
[brs, 1H, H(His)], 5.27 [m, 1H, H6(Chol)], 6.15 [brs, 1H, -NH-BOC],60–120 mesh). Reversed-phase analytical HPLC analysis demon-
strated the purity levels of the novel cationic lipids 1–3 to be more 6.95 [brs, 1H, -CONH-CH2-CH2-O-], 7.15 [s, 1H, H5(Imi)], and 7.95 [s,
1H, H2(Imi)].than 95% (Figure S2, Supplemental Data). All three final lipids (1–3)
Step b. Selective acid deprotection of the productwere found to be stable in methanol solution and showed no extra-
obtained in step aneous peaks in HPLC after the methanol solution was maintained
Nim, N di-BOC-histidine-cholesteryl-ethylamide (450 mg, 0.59at room temperature.
mmol, product of step a above) was taken in a 25 ml round-bottomed
flask and dissolved in 1,4 dioxan (2 ml). 2N HCl (0.3 ml) was addedSynthesis of Lipid 1, Shown in Figure 1A
to the reaction mixture and stirred at room temperature for 45 min.Step a. Synthesis of cholesteryl Nim, N di-trityl-L-histidine-
Ether (15 ml) was added to the reaction mixture, the aqueous layerethylamide, intermediate I
was separated, and the organic layer was dried with anhydrousA solution of Nim, N-di-trityl-L-histidine (600 mg, 0.94 mmol) in dry
sodium sulfate, filtered, and concentrated on a rotary evaporator.dimethylformamide (3 ml) was taken in a 25 ml two-necked, round-
Column-chromatographic purification (with 60–120 mesh size silicabottomed flask under nitrogen atmosphere and cooled to 0C. To
and 3%–4%, v/v, methanol in chloroform as the eluent) of the residuethe cooled solution, carbonyl diimidazole (152 mg, 0.94 mmol) dis-
afforded the product N-BOC-histidine cholesteryl ethylamide as asolved in dry dimethylformamide (1 ml) was added dropwise, and
white solid (371.6 mg, 95% yield,. Rf 	 0.5 in 10% methanol inthe reaction was allowed to come to room temperature within a
chloroform).period of 30 min. After the reaction mixture was stirred at room
1H NMR of N-BOC-histidine-cholesteryl-ethylamide (300 MHz,temperature for 2 hr, 2-aminoethyl cholesteryl ether, ACE (401 mg,
CDCl3):  	 0.65-2.35 [m, 43H, cholesteryl skeleton], 1.40 [s, 9H,0.94 mmol) dissolved in dry dichloromethane (2 ml) was added, and
(CH3)3COCONH-], 2.90–3.15 [m, 3H, H
(His)  H3(Chol)], 3.30–3.55the stirring was continued at room temperature for 14 hr. Brine
[m, 4H, -CONH-CH2-CH2-O-], 4.40 [brs, 1H, H(His)], 5.27 [m, 1H,solution (20 ml) was added to the reaction mixture; the reaction
H6(Chol)], 5.90 [brs, 1H, -NH-BOC], 6.82 [brs, 1H, H5(Imi)], 7.25 [brs,mixture was extracted with chloroform (4  20 ml); the chloroform
1H, -CONH-CH2-CH2-O-], and 7.70 [brs, 1H, H2(Imi)].extract was washed with water (3  30 ml), dried over anhydrous
Step c. Synthesis of N-BOC, Nim-Ts- histidine-cholesteryl-sodium sulfate, and filtered; and the filtrate was concentrated with a
ethylamide, intermediate II, shown in Figure 1Brotary evaporator. Column-chromatographic purification (for which
N-BOC-histidine-cholesteryl-ethylamide (200 mg, 0.30 mmol, pre-60–120 mesh size silica were used along with 40%–50% (v/v) ethyl
pared in step b above) and 4-N,N-dimethyl-aminopyridine (pinch)acetate in hexane as the eluent) of the residue afforded the title
were dissolved in 1 ml of dry dichloromethane under nitrogen atmo-compound as a white solid (248 mg, 25% yield, Rf 	 0.5 in 60%, sphere in a two-necked, 25 ml round-bottomed flask. The solution
ethyl acetate in hexane).
was cooled to 0C, p-TsCl (68.7 mg, 0.36 mmol) dissolved in dry1H NMR of I (200 MHz, CDCl3):  	 0.70–2.40 [m, 43H, cholesteryl dichloromethane (1 ml) and dry pyridine (0.2 ml) were added, and
skeleton], 2.60–2.90 [m, 2H, H
(His)], 3.00–3.20 [m, 1H, H3(Chol)], the reaction mixture was stirred constantly at room temperature for
3.30–3.55 [m, 4H, -CONH-CH2-CH2-], 3.90–4.00 [m, 1H, H(His)], 11 hr. Water (15 ml) was added to the reaction mixture, the reaction
5.10–5.15 [m, 1H, -NH-trityl], 5.25–5.35s [m, 1H, H6(Chol)], 6.40 [s, mixture was extracted with chloroform (4  15 ml), the chloroform
1H, H5(Imi)], 7.00–7.50 [m, 30H, H(trityl)], and 7.60 [brs, 1H, H2(Imi)]. extract was washed with aqueous CuSO4 (3 10 ml), dried withStep b. Acid deprotection and chloride ion exchange of I anhydrous sodium sulfate, and filtered, and the filtrate was concen-
Cholesteryl Nim, N-di-trityl-L-histidine-ethylamide, I (170.8 mg, 0.16 trated on a rotary evaporator. Column-chromatographic purification
mmol, prepared above in step a) was taken in a 10 ml round-bot- (with 60–120 mesh size silica and 50%–60%, v/v, ethyl acetate in
tomed flask and dissolved in 1.0 ml of TFA:water (2:1, v/v). After the hexane as the eluent) of the residue afforded the title compound as
mixture was stirred at room temperature for 2 hr, the solvent was a white solid (125.2 mg, 50.6% yield, Rf 	 0.7 in 70:30 ethyl acetate/
evaporated completely by nitrogen flow. Column-chromatographic hexane).
purification (for which 60–120 mesh silica gel size were used along 1H NMR of II (200 MHz, CDCl3):  	 0.60-2.35 [m, 43H, cholesteryl
with 8%–10% methanol in chloroform, v/v, as the eluent) of the skeleton], 1.40 [s, 9H, (CH3)3COCONH-], 2.40 [s, 3H, CH3-C6H4-
residue after chloride ion exchange in Amberlyst A-26 with methanol SO2-], 2.85–3.05 [m, 3H, H
(His)H3(Chol)], 3.05–3.35 [m, 4H, -CONH-
as the eluent afforded lipid 1 as a white solid (97.7 mg, 99.8% yield, CH2-CH2-O-], 4.30 [brs, 1H, H(His)], 5.22 [brs, 1H, H6(Chol)], 5.90
Rf 	 0.5 in 20:80 methanol:chloroform). [m, 1H, -NH-BOC], 6.82 [brs, 1H, -CONH-CH2-CH2-O-], 7.00 [s, 1H,1H NMR of lipid 1 (200 MHz, CDCl3  CD3OD):  	 0.65–2.40 [m, H5(Imi)], 7.25 [d, 2H, H(meta, Tos)], 7.70 [d, 2H, H(ortho, Tos)], and
43H, cholesteryl skeleton], 3.05–3.15 [m, 1H, H3(Chol)], 3.15–3.25 7.80 [s, 1H, H2(Imi)].
[m, 2H, H
(His)], 3.40 [m, 2H, -CONH-CH2-CH2-], 3.55 [m, 2H, -CONH- Step d. Acid deprotection and chloride ion exchange
CH2-CH2-], 4.00–4.10 [m, 1H, H(His)], 5.30 [d, 1H, H6(Chol)], 7.15 [s, of intermediate II, shown in Figure 2B
1H, H5(Imi)], and 8.00 [s, 1H, H2(Imi)]. N-BOC, Nim-Ts-histidine-cholesteryl-ethylamide (120 mg, 0.15
FABMS (LSIMS): m/z: 567 [M] for C35H59N4O2. mmol, II, prepared in step c above) was taken in a 10 ml round-
bottomed flask and dissolved in 1.25 ml of TFA:dichloromethane
Synthesis of Lipid 2, Shown in Figure 1B (DCM) (1:4, v/v). After the mixture was stirred at room temperature
Step a. Coupling of ACE with Nim, N, di-BOC-histidine for 40 min., the solvent was evaporated completely under nitrogen
Nim, N-di-BOC Histidine (1.32 g, 3.72 mmol) and N,N-dimethyl-4- flow. Column-chromatographic purification (with 60–120 mesh size
aminopyridine (456 mg, 3.72 mmol) were taken in a 50 ml two- silica and 6%–7%, v/v, methanol in chloroform as the eluent) of the
necked, round-bottomed flask and dissolved in 4 ml of dry dichloro- residue and subsequent chloride ion exchange in Amberlyst A-26
methane under nitrogen atmosphere. Dicyclohexyl carbodiimide with methanol as the eluent afforded lipid 2 as a white solid (88.3
(769.6 mg, 3.72 mmol) dissolved in 2 ml of dry dichloromethane mg, 80% yield, Rf 	 0.2 in 5% methanol in chloroform).
was added to the solution, and after 10 min of stirring at room 1H NMR of lipid 2 (200 MHz, CDCl3):  	 0.60–2.30 [m, 43H, choles-
teryl skeleton], 2.40 [s, 3H, CH3-C6H4-SO2-], 3.00–3.50 [m, 7H,temperature, ACE (1.6 g, 3.72 mmol) dissolved in 3 ml of dry dichloro-
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(His) H3(Chol) -CONH-CH2-CH2-], 4.40 [brs, 1H, H(His)], 5.25 Transfections
Two days prior to transfection, cells were seeded at 1  105 cells[brs, 1H, H6(Chol)], 7.20–7.40 [m, 3H, H5(Imi)  H(meta, Tos)], 7.80
[d, 2H, H(ortho, Tos)], 8.00 [s, 1H, H2(Imi)], and 8.40 [brs, 1H, -CONH- in 1 ml culture medium in a 24-well plate. At the time of the experi-
ment, cell cultures were 80% confluent, and lipofections were per-CH2-CH2-O-].
ESMS: m/z: 722 [M] for C42H65N4O2S. formed as described below. Liposomes were prepared by the etha-
nol injection method: 15 l of an ethanol solution of a 5.4 mM or a
2.7 mM lipid mixture—lipid 1/DOPE, lipid 2/DOPE, or lipid 3/DOPE
Synthesis of Lipid 3, Shown in Figure 1C (the lipid:DOPE molar ratio was 2:1)—was injected rapidly into 200
Step a. Coupling of ACE with Nim, N-di-BOC-alanine l of 10 mM HEPES buffer (pH 7.4). After 15 min at room temperature,
N-BOC-alanine (123.8 mg, 0.70 mmol) and N,N-dimethylaminopyri- the liposome solution was mixed with the plasmid (5 g in 20 l of
dine (85.4 mg, 0.70 mmol) were taken in a 25 ml two-necked, round- 10 mM HEPES buffer [pH 7.4]), and the mixture was incubated for
bottomed flask and dissolved in 2 ml of dry dichloromethane under an additional 15 min at room temperature. The lipoplex solution was
nitrogen atmosphere. Dicyclohexyl carbodiimide (144 mg, 0.70 diluted to 1 ml with serum-free medium, and the NaCl concentration
mmol) dissolved in 1 ml of dry dichloromethane was added to the was adjusted to 0.15 M with a 5 M NaCl solution. Cells were washed
solution. After 10 min of stirring at room temperature, ACE (300 mg, two times with serum-free culture medium before incubation with
0.70 mmol) dissolved in 2 ml of dry dichloromethane was added 2.5 g plasmid. When Bafilomycin A1 (Sigma) was used, cells were
and the reaction mixture, which was stirred constantly at room tem- pretreated for 30 min at 37C with Bafilomycin A1, and the transfec-
perature for 23 hr. The precipitate obtained was filtered, and the tion was conducted in presence of the drug. When indicated, cells
filtrate was concentrated on a rotary evaporator. Column-chromato- were transfected in the presence of 100 M chloroquine (Sigma).
graphic purification (with 60–120 mesh size silica and 10%–14%, After 4 hr at 37C, the medium was removed, and cells were cultured
v/v, acetone in hexane as the eluent) of the residue afforded the for 24 hr or 48 hr at 37C in complete culture medium without any
product N-BOC-alanine-cholesteryl-ethylamide as a white solid additives.
(251.1 mg, 59.9% yield).
1H NMR of N-BOC-alanine-cholesteryl-ethylamide (200 MHz, Luciferase Assay
CDCl3):  	 0.60–2.35 [m, 46H, cholesteryl skeleton  H
(Ala)], 1.40 For measuring luciferase gene expression, the luminescence activity
[s, 9H, (CH3)3COCONH-], 3.15 [m, 1H, H3(Chol)], 3.30–3.50 [m, 4H, was monitored according to De Wet et al. [31]. The medium was
-NH-CH2-CH2-O-], 4.10 [brs, 1H, H(Ala)], 4.95 [brs, 1H, BOCNH-], discarded, and cells were washed three times with PBS. The homog-
5.30 [s, 1H, H6(Chol)], and 6.35 [brs, 1H, -CONH-CH2- CH2-O-]. enization buffer (200 l of 8 mM MgCl2, 1 mM DTT, 1 mM EDTA,
Step b. Acid deprotection and chloride ion exchange 1% Triton X-100, 15% glycerol, and 25 mM Tris-phosphate buffer
of N-BOC-alanine-cholesteryl-ethylamide [pH 7.8]) was poured into each well, and tissue culture plates were
N-BOC-alanine cholesteryl ethylamide, (140 mg, 0.23 mmol, pre- kept for 15 min at 20C. The solution was recovered and spun down
pared in step a above) was taken in a 25 ml round-bottomed flask (5 min at 800 g). Ninety-five microliters of a 2 mM ATP solution in
and dissolved in 1.2 ml of TFA:DCM (1:4, v/v). After the mixture was the homogenization buffer without Triton X-100 was added to 60
stirred at room temperature for 1.5 hr., the solvent was evaporated l supernatant, and the solution was shaken with a vortex. The
completely by nitrogen flow. Column-chromatographic purification luminescence was recorded for 4 s in a Lumat LB 9501 luminometer
(with 60–120 mesh size silica and 5%–7%, v/v, methanol in chloro- (Berthold, Wildbach, Germany) upon addition of 150 l of a 167 mM
form as the eluent) of the residue and subsequent chloride ion ex- luciferin solution in water. Measurements were done in duplicate.
change in Amberlyst A-26 with methanol as the eluent afforded lipid The number of RLU of 1 pg/ml of luciferase was 2000 under these
3 as a white solid (95 mg, 75.3% yield, Rf 	 0.3 in 10% methanol assay conditions. The data shown correspond to the number of
in chloroform). relative light units (RLU) per mg proteins. Proteins were determined
1H NMR of lipid 3 (200 MHz, CDCl3):  	 0.60-2.35 [m, 46H, cholest- on each sample via a modified bicinchoninic acid (BCA) colorimetric
eryl skeleton  H
(Ala)], 3.15 [m, 1H, H3(Chol)], 3.20–3.60 [m, 4H, assay [32, 33].
-NH-CH2-CH2-], 4.25 [brs, 1H, H(Ala)], 5.30 [s, 1H, H6(Chol)], and
8.30 [brs, 1H, -CONH-CH2-]. Plasmid Uptake
FABMS (LSIMS): m/z: 501 [M] for C32H57N2O2. 293T7 cells were transfected for 2–4 hr as described above, with
lipoplexes made with YOYO-labeled DNA. After being washed, the
cells were harvested with trypsin, and the cell-associated fluores-Cells and Cell Culture
cence intensity was measured by flow cytometry (FACSort, BectonHuman hepatocarcinoma HepG2 cells (8055 HB, ATCC, Rockville,
Dickinson).MD) and human epithelial ovary carcinoma HeLa cells (CCL21,
ATCC) were cultured in MEM containing 10% heat-inactivated fetal
Toxicity Assaybovine serum (FBS, Life Technologies, Cergy Pontoise, France),
The cell viability was evaluated with the colorometric MTT assay2 mM L-glutamine (Life Technologies), 100 units/ml penicillin (Life
[34]. MTT (5 mg/ml PBS) was added to cell culture and incubatedTechnologies) and 100 Units/ml streptomycin (Life Technologies).
for 4 hr at 37C. MTT converted to an insoluble dye in living cellsHuman embryo kidney 293T7 cells (kindly given by Drs. L. Huang
was then solubilized with acidic isopropanol. The absorbance wasand M. Brisson at the University of Pittsburgh, Pittsburgh, PA; [22])
measured at 570 nm and expressed as a percentage of the ab-were cultured in DMEM containing 10% FBS, 2 mM L-glutamine,
sorbance measured for untransfected cells cultured under the same1 mM sodium pyruvate, 100 units/ml penicillin, 100 units/ml strepto-
conditions as those used for transfected cells.mycin, and 400 g/ml geneticin. Cells were mycoplasma free, as
evidenced by the bis-benzimidazole (Hoechst 33258, Molecular
Determination of Apparent pKaProbes) method [30].
For determining the apparent pKa, 14–17 mol (10 mg) of the lipids
were dryed in chloroform solution in centrifuge tubes under vacuum
for 6 hr. The dried lipids were dissolved in 10 ml of water containingPlasmids
0.5% Triton-X-100 (pH 2.5). The aqueous Triton X-100 solution ofpCMVLuc (pUT650, 5.15 kb, Cayla, Toulouse, France) and pT7Luc
the lipids was titrated manually by gradual addition of an aqueous(kindly given by Dr. M. Brisson) were plasmid DNA encoding the
20 mM NaOH solution via a digital pH meter. The pKa of the lipidsfirefly luciferase under the control of the human cytomegalovirus
was determined from differential titration curves.and the bacteriophage T7 RNA polymerase promoter, respectively.
Supercoiled plasmid DNA was isolated by a standard alkaline lysis
method, and purification was carried out with the QIAGEN Plasmid Measurements of Size and Zeta Potentials ()
Liposomes at 81 M were prepared by a rapid injection of 15 l ofMega Kit (QIAGEN, Courtaboeuf, France). For preparation of YOYO-
labeled pUT650, 9 l YOYO (1 mM) (Molecular Probes) was mixed a 5.4 mM lipid mixture in ethanol (lipid 1/DOPE, lipid 2/DOPE, or
lipid 3/DOPE; a lipid:DOPE molar ratio of 2:1 was used) into 200 lwith 100 l plasmid (1 mg/ml) at 20C for 30 min, and the solution
was then dialyzed 24 hr at 4C against H2O. of 10 mM HEPES buffer (pH 7.4). After 15 min at room temperature,
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the liposomes were diluted to 1 ml in 10 mM HEPES buffer at various 10. Zabner, J., Fasbender, A.J., Moninger, T., Poellinger, K.A., and
Welsh, M.J. (1995). Cellular and molecular barriers to gene trans-pH levels. Lipoplexes were prepared as described above. The 
potential of liposomes and lipoplexes was measured by electropho- fer by a cationic lipid. J. Biol. Chem. 270, 18997–19007.
11. Xu, Y., and Szoka, F.C., Jr. (1996). Mechanism of DNA releaseretic mobility with Zeta Sizer 3000 (Malvern Instruments, Orsay,
France). The following parameters were set up: viscosity, 0.891 cP; from cationic liposome/DNA complexes used in cell transfec-
tion. Biochemistry 35, 5616–5623.dielectric constant, 79; temperature, 25C; F(Ka), 1.50 (Smoluchow-
sky); maximum voltage of the current, 15 V. The system was cali- 12. Budker, V., Gurevich, V., Hagstrom, J.E., Bortzov, F., and Wolff,
J.A. (1996). pH-sensitive cationic liposomes: a new syntheticbrated with DTS 5050 standard from Malvern. Measurements were
done ten times with the zero-field correction. The  potentials were virus-like vector. Nat. Biotechnol. 14, 760–764.
13. Remy, J.-S., Goula, D., Steffan, A.-M., Zanta, M.A., Bousiff, O.,calculated with the Smoluchowsky approximation. The size of lipo-
somes and lipoplexes was measured by quasi-elastic laser light Behr, J.-P., and Demenix, B. (1998). Self-Assembling Com-
plexes for Gene Delivery, A.V. Kabanov, P.L. Felgner, and L.scattering (QELS) with Zeta Sizer 3000 in 10 mM HEPES buffer (pH
7.4) in the absence and the presence of 0.15 M NaCl ten times with Seymour, Eds. (John Wiley & Sons).
14. Heyes, J.A., Niculescu-Duvaz, D., Cooper, R.G., and Springer,a sample refractive index of 1.59 and a viscosity of 0.89. The system
C.J. (2002). Synthesis of novel cationic lipids: effect of structuralwas calibrated with the 200  5 nm polystyrene polymer (Duke
modification on the efficiency of gene transfer. J. Med. Chem.Scientific Corps Palo Alto, CA). The diameter of liposomes and
45, 99–114.lipoplexes was calculated in the automatic mode.
15. Putnam, D., Gentry, C.A., Pack, D.W., and Langer, R. (2001).
Polymer-based gene delivery with low cytotoxicity by a uniqueSupplemental Data
balance of side-chain termini. Proc. Natl. Acad. Sci. USA 98,Experimental details for the preparation of the common intermediate
1200–1205.ACE, reversed HPLC chromatograms for the final lipids 1–3, 1H NMR
16. Midoux, P., and Monsigny, M. (1999). Efficient gene transfer byspectra of lipid 2, and 1H NMR spectra for all intermediates involved
histidylated polysine/pDNA complexes. Bioconjug. Chem. 10,in the synthesis of lipid 2 (total 9 pages) are included as supplemental
406–411.data with this article online at http://www.chembiol.com/cgi/
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